From Name

From Email

To Name

To Email

Message

Empagliflozin — Kidney Protection Regardless of An Initial 'Egfr Dip'

from Medical Xpress

Empagliflozin — Kidney Protection Regardless of An Initial 'Egfr Dip' Medical Xpress Empagliflozin (EMPA), a selective inhibitor of sodium/glucose cotransporter 2 (SGLT2 inhibitors, "gliflozines"), reduces CKD progression in Type 2 diabetics (T2D) with cardiovascular disease, presumably by lowering intraglomerular pressure. Positive effects of the drug on the cardiovascular risk of patients have also been observed. READ MORE

more